![Al-Ola Abdallah: Plasma cell infiltration rates with 18F-FDG PET/CT in multiple myeloma](https://oncodaily.com/pub/uploads/2025/01/Al-Ola-Abdallah-e1739105882156-1280x720.jpg)
Al-Ola Abdallah: Plasma cell infiltration rates with 18F-FDG PET/CT in multiple myeloma
Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on X about a recent paper by Özge Ulaş Babacan et al. published in MIRT:
“Relationship of Plasma Cell Infiltration Rates with 18F-FDG PET/CT.
Data and Hematological Parameters in Multiple Myeloma (MM).
Aim: To determine if 18F-FDG-PET/CT could potentially replace or reduce the need for repeated BMBx in diagnosing and monitoring MM!
Retrospective study of 71 patients diagnosed with MM between 2014 and 2021 who underwent PET/CT for staging and had not yet received treatment
- Data collected included BM aspiration results, creatinine, albumin, calcium, neutrophil, lymphocyte, beta-2 microglobulin, and platelet values), and PET/CT scan results
- The systemic inflammatory index (SII) was calculated using the formula: neutrophil x lymphocyte/ platelet
- Bone lesion evaluation considered uptake greater than background bone marrow activity as positive. Diffuse bone marrow infiltration was defined as a bone marrow SUV max > hepatic SUV max.
Results:
- No significant correlation between BM SUV max and plasma cell infiltration rate (p=0.07)
- Significant correlation between visually increased BM uptake on PET/CT and higher plasma cell infiltration rates (p=0.037)
- Significant correlation between the SUV max of lytic bone lesions showing increased 18F-FDG uptake and SII (p=0.025, r=0.330)
- Significant correlation between BM SUV max and creatinine elevation (p=0.032)
- PET/CT may be an advantage over BMBx in the diagnosis and evaluation of MM recurrence and may prevent repeated BMBx
- The correlation between lytic lesion SUV max and SII suggests that higher lesion SUV max values and SII values could indicate a worse prognosis.
- Elevated serum Cr levels correlated with BM SUV max, potentially linked to disease aggressiveness and poorer prognosis
Limitations: Beside its a retrospective study there was inability to reach the targeted number of patients and to evaluate the prognosis of the patients.”
Authors: Özge Ulaş Babacan, Zekiye Hasbek, Hatice Terzi.
More posts featuring Al-Ola Abdallah.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023